The 12 most common cold email deliverability mistakes and how to fix them for healthcare and life sciences

This edition is written for commercial leaders at healthtech, medtech, and life-sciences companies. In healthcare and life sciences, healthcare buyers move under regulatory constraint and reward domain-specific messaging, so the way you install cold email deliverability has to reflect that reality from day one.

Every cold email deliverability failure we have investigated maps to one of the mistakes below. They repeat because they are structurally easy to make.

Mistake one, the foundational one: sending from your primary domain without warmup or separation. Fix by naming an owner and writing kill criteria before you spend a dollar.

Mistake two: mistaking volume for progress. Fix by making inbox placement rate across Google and Microsoft the only weekly headline number.

The binding constraint we see in healthcare and life sciences is almost always regulated-sale cycle length, not intent. Cold email deliverability is only useful in this vertical when it is pointed at that constraint — not at a generic growth number borrowed from another category.

Mistake three: buying tools before defining the workflow. Fix by drawing the workflow on paper first and buying only what the paper shows.

Mistake four: shipping without a quality gate. Fix by requiring a human eyeball on every artefact for the first four weeks.

Mistake five: ignoring the trigger. Cold email deliverability works when reply rate is a function of inbox placement before it is a function of copy; without a real trigger the model is guesswork.

Mistake six through twelve: cascade from the first five. Fix the top five and most of the others resolve themselves inside a month.

Concretely for healthcare and life sciences: the healthcare teams that install this get past procurement instead of dying in it. That is the reason it is worth installing cold email deliverability properly rather than half-heartedly across three vendors.